Skip to main content
Premium Trial:

Request an Annual Quote

But Will They Be Able to Feed It Simulated Gingko Biloba?

Technology Review has a story about a cool project: scientists using a computer to simulate a brain, right down to the individual neuron. Known as the Blue Brain project, the effort is aimed at reverse-engineering a brain -- currently, a sort of generic mammalian brain, and ultimately a human one. A successful model could allow researchers to perform in silico testing of drug dosing and effects, among other virtual experiments. GTO would like to know whether the simulated brain could be used on days when human brains refuse to work, and if so, where do we sign up?

In completely unrelated but still brain-focused news, MedGadget has a post on the winning image from the Olympus life science imaging contest. Researchers from Harvard developed a technique to show neurons and how they connect -- the resulting picture is well worth a look.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.